Steven Cohen Cytokinetics Inc Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $1.32 Million - $2.06 Million	-27,500 Reduced 57.89%	20,000 $1.08 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $28.8 Million - $48.9 Million	-452,500 Reduced 90.5%	47,500 $3.33 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $13.4 Million - $41.7 Million	500,000 New	500,000 $41.7 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.85B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.